Global Major Depressive Disorder Market Research Report 2023

Major depressive disorder, also known as major depression and clinical depression, is a mental disorder characterized by loss of interest and pleasure in enjoyable environment. People are affected in different ways by major depression. Some people have trouble sleeping, feel agitated and irritable, and have sudden weight loss. Moreover, they can have Others mental and physical symptoms such as fatigue, memory loss, feeling of hopelessness, body aches, headaches, and thoughts of suicide.

The global Major Depressive Disorder market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

In terms of geography, North America dominates the global major depressive disorder market due to increased awareness about various depression conditions in the region. The U.S. represents the largest market for major depressive disorder in North America, followed by Canada. In Europe, Germany, France, the U.K., Italy, and Spain account for a major share of the major depressive disorder market. This market in Asia is expected to expand at a significant rate over the next five years. This is due to various companies setting up manufacturing facilities in the region. Moreover, increasing awareness about various depression episodes and rise in geriatric population are also driving the growth of the market in the region. India, China, and Japan are expected to be the fastest growing major depressive disorder markets in Asia.

This report aims to provide a comprehensive presentation of the global market for Major Depressive Disorder, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Major Depressive Disorder.

The Major Depressive Disorder market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Major Depressive Disorder market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Major Depressive Disorder companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Major Depressive Disorder Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Drugs Therapy

1.2.3 Biological Therapy

1.2.4 Meditation

1.2.5 Physiothersapy

1.2.6 Others

1.3 Market by Application

1.3.1 Global Major Depressive Disorder Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Under 25 Years Old

1.3.3 25-45 Years Old

1.3.4 Above 45 Years Old

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Major Depressive Disorder Market Perspective (2018-2029)

2.2 Major Depressive Disorder Growth Trends by Region

2.2.1 Global Major Depressive Disorder Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Major Depressive Disorder Historic Market Size by Region (2018-2023)

2.2.3 Major Depressive Disorder Forecasted Market Size by Region (2024-2029)

2.3 Major Depressive Disorder Market Dynamics

2.3.1 Major Depressive Disorder Industry Trends

2.3.2 Major Depressive Disorder Market Drivers

2.3.3 Major Depressive Disorder Market Challenges

2.3.4 Major Depressive Disorder Market Restraints

3.1 Global Top Major Depressive Disorder Players by Revenue

3.1.1 Global Top Major Depressive Disorder Players by Revenue (2018-2023)

3.1.2 Global Major Depressive Disorder Revenue Market Share by Players (2018-2023)

3.2 Global Major Depressive Disorder Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Major Depressive Disorder Revenue

3.4 Global Major Depressive Disorder Market Concentration Ratio

3.4.1 Global Major Depressive Disorder Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Major Depressive Disorder Revenue in 2022

3.5 Major Depressive Disorder Key Players Head office and Area Served

3.6 Key Players Major Depressive Disorder Product Solution and Service

3.7 Date of Enter into Major Depressive Disorder Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Major Depressive Disorder Historic Market Size by Type (2018-2023)

4.2 Global Major Depressive Disorder Forecasted Market Size by Type (2024-2029)

5.1 Global Major Depressive Disorder Historic Market Size by Application (2018-2023)

5.2 Global Major Depressive Disorder Forecasted Market Size by Application (2024-2029)

6.1 North America Major Depressive Disorder Market Size (2018-2029)

6.2 North America Major Depressive Disorder Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Major Depressive Disorder Market Size by Country (2018-2023)

6.4 North America Major Depressive Disorder Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Major Depressive Disorder Market Size (2018-2029)

7.2 Europe Major Depressive Disorder Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Major Depressive Disorder Market Size by Country (2018-2023)

7.4 Europe Major Depressive Disorder Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Major Depressive Disorder Market Size (2018-2029)

8.2 Asia-Pacific Major Depressive Disorder Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Major Depressive Disorder Market Size by Region (2018-2023)

8.4 Asia-Pacific Major Depressive Disorder Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Major Depressive Disorder Market Size (2018-2029)

9.2 Latin America Major Depressive Disorder Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Major Depressive Disorder Market Size by Country (2018-2023)

9.4 Latin America Major Depressive Disorder Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Major Depressive Disorder Market Size (2018-2029)

10.2 Middle East & Africa Major Depressive Disorder Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Major Depressive Disorder Market Size by Country (2018-2023)

10.4 Middle East & Africa Major Depressive Disorder Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Pfizer

11.1.1 Pfizer Company Detail

11.1.2 Pfizer Business Overview

11.1.3 Pfizer Major Depressive Disorder Introduction

11.1.4 Pfizer Revenue in Major Depressive Disorder Business (2018-2023)

11.1.5 Pfizer Recent Development

11.2 Eli Lilly

11.2.1 Eli Lilly Company Detail

11.2.2 Eli Lilly Business Overview

11.2.3 Eli Lilly Major Depressive Disorder Introduction

11.2.4 Eli Lilly Revenue in Major Depressive Disorder Business (2018-2023)

11.2.5 Eli Lilly Recent Development

11.3 H. Lundbeck

11.3.1 H. Lundbeck Company Detail

11.3.2 H. Lundbeck Business Overview

11.3.3 H. Lundbeck Major Depressive Disorder Introduction

11.3.4 H. Lundbeck Revenue in Major Depressive Disorder Business (2018-2023)

11.3.5 H. Lundbeck Recent Development

11.4 Otsuka Pharmaceutical

11.4.1 Otsuka Pharmaceutical Company Detail

11.4.2 Otsuka Pharmaceutical Business Overview

11.4.3 Otsuka Pharmaceutical Major Depressive Disorder Introduction

11.4.4 Otsuka Pharmaceutical Revenue in Major Depressive Disorder Business (2018-2023)

11.4.5 Otsuka Pharmaceutical Recent Development

11.5 AstraZeneca

11.5.1 AstraZeneca Company Detail

11.5.2 AstraZeneca Business Overview

11.5.3 AstraZeneca Major Depressive Disorder Introduction

11.5.4 AstraZeneca Revenue in Major Depressive Disorder Business (2018-2023)

11.5.5 AstraZeneca Recent Development

11.6 Alkermes

11.6.1 Alkermes Company Detail

11.6.2 Alkermes Business Overview

11.6.3 Alkermes Major Depressive Disorder Introduction

11.6.4 Alkermes Revenue in Major Depressive Disorder Business (2018-2023)

11.6.5 Alkermes Recent Development

11.7 Takeda Pharmaceutical

11.7.1 Takeda Pharmaceutical Company Detail

11.7.2 Takeda Pharmaceutical Business Overview

11.7.3 Takeda Pharmaceutical Major Depressive Disorder Introduction

11.7.4 Takeda Pharmaceutical Revenue in Major Depressive Disorder Business (2018-2023)

11.7.5 Takeda Pharmaceutical Recent Development

11.8 Naurex

11.8.1 Naurex Company Detail

11.8.2 Naurex Business Overview

11.8.3 Naurex Major Depressive Disorder Introduction

11.8.4 Naurex Revenue in Major Depressive Disorder Business (2018-2023)

11.8.5 Naurex Recent Development

11.9 Euthymics Bioscience

11.9.1 Euthymics Bioscience Company Detail

11.9.2 Euthymics Bioscience Business Overview

11.9.3 Euthymics Bioscience Major Depressive Disorder Introduction

11.9.4 Euthymics Bioscience Revenue in Major Depressive Disorder Business (2018-2023)

11.9.5 Euthymics Bioscience Recent Development

11.10 E-therapeutics

11.10.1 E-therapeutics Company Detail

11.10.2 E-therapeutics Business Overview

11.10.3 E-therapeutics Major Depressive Disorder Introduction

11.10.4 E-therapeutics Revenue in Major Depressive Disorder Business (2018-2023)

11.10.5 E-therapeutics Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Major Depressive Disorder Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Drugs Therapy

    Table 3. Key Players of Biological Therapy

    Table 4. Key Players of Meditation

    Table 5. Key Players of Physiothersapy

    Table 6. Key Players of Others

    Table 7. Global Major Depressive Disorder Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 8. Global Major Depressive Disorder Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 9. Global Major Depressive Disorder Market Size by Region (2018-2023) & (US$ Million)

    Table 10. Global Major Depressive Disorder Market Share by Region (2018-2023)

    Table 11. Global Major Depressive Disorder Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 12. Global Major Depressive Disorder Market Share by Region (2024-2029)

    Table 13. Major Depressive Disorder Market Trends

    Table 14. Major Depressive Disorder Market Drivers

    Table 15. Major Depressive Disorder Market Challenges

    Table 16. Major Depressive Disorder Market Restraints

    Table 17. Global Major Depressive Disorder Revenue by Players (2018-2023) & (US$ Million)

    Table 18. Global Major Depressive Disorder Market Share by Players (2018-2023)

    Table 19. Global Top Major Depressive Disorder Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Major Depressive Disorder as of 2022)

    Table 20. Ranking of Global Top Major Depressive Disorder Companies by Revenue (US$ Million) in 2022

    Table 21. Global 5 Largest Players Market Share by Major Depressive Disorder Revenue (CR5 and HHI) & (2018-2023)

    Table 22. Key Players Headquarters and Area Served

    Table 23. Key Players Major Depressive Disorder Product Solution and Service

    Table 24. Date of Enter into Major Depressive Disorder Market

    Table 25. Mergers & Acquisitions, Expansion Plans

    Table 26. Global Major Depressive Disorder Market Size by Type (2018-2023) & (US$ Million)

    Table 27. Global Major Depressive Disorder Revenue Market Share by Type (2018-2023)

    Table 28. Global Major Depressive Disorder Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 29. Global Major Depressive Disorder Revenue Market Share by Type (2024-2029)

    Table 30. Global Major Depressive Disorder Market Size by Application (2018-2023) & (US$ Million)

    Table 31. Global Major Depressive Disorder Revenue Market Share by Application (2018-2023)

    Table 32. Global Major Depressive Disorder Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 33. Global Major Depressive Disorder Revenue Market Share by Application (2024-2029)

    Table 34. North America Major Depressive Disorder Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 35. North America Major Depressive Disorder Market Size by Country (2018-2023) & (US$ Million)

    Table 36. North America Major Depressive Disorder Market Size by Country (2024-2029) & (US$ Million)

    Table 37. Europe Major Depressive Disorder Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 38. Europe Major Depressive Disorder Market Size by Country (2018-2023) & (US$ Million)

    Table 39. Europe Major Depressive Disorder Market Size by Country (2024-2029) & (US$ Million)

    Table 40. Asia-Pacific Major Depressive Disorder Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 41. Asia-Pacific Major Depressive Disorder Market Size by Region (2018-2023) & (US$ Million)

    Table 42. Asia-Pacific Major Depressive Disorder Market Size by Region (2024-2029) & (US$ Million)

    Table 43. Latin America Major Depressive Disorder Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 44. Latin America Major Depressive Disorder Market Size by Country (2018-2023) & (US$ Million)

    Table 45. Latin America Major Depressive Disorder Market Size by Country (2024-2029) & (US$ Million)

    Table 46. Middle East & Africa Major Depressive Disorder Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 47. Middle East & Africa Major Depressive Disorder Market Size by Country (2018-2023) & (US$ Million)

    Table 48. Middle East & Africa Major Depressive Disorder Market Size by Country (2024-2029) & (US$ Million)

    Table 49. Pfizer Company Detail

    Table 50. Pfizer Business Overview

    Table 51. Pfizer Major Depressive Disorder Product

    Table 52. Pfizer Revenue in Major Depressive Disorder Business (2018-2023) & (US$ Million)

    Table 53. Pfizer Recent Development

    Table 54. Eli Lilly Company Detail

    Table 55. Eli Lilly Business Overview

    Table 56. Eli Lilly Major Depressive Disorder Product

    Table 57. Eli Lilly Revenue in Major Depressive Disorder Business (2018-2023) & (US$ Million)

    Table 58. Eli Lilly Recent Development

    Table 59. H. Lundbeck Company Detail

    Table 60. H. Lundbeck Business Overview

    Table 61. H. Lundbeck Major Depressive Disorder Product

    Table 62. H. Lundbeck Revenue in Major Depressive Disorder Business (2018-2023) & (US$ Million)

    Table 63. H. Lundbeck Recent Development

    Table 64. Otsuka Pharmaceutical Company Detail

    Table 65. Otsuka Pharmaceutical Business Overview

    Table 66. Otsuka Pharmaceutical Major Depressive Disorder Product

    Table 67. Otsuka Pharmaceutical Revenue in Major Depressive Disorder Business (2018-2023) & (US$ Million)

    Table 68. Otsuka Pharmaceutical Recent Development

    Table 69. AstraZeneca Company Detail

    Table 70. AstraZeneca Business Overview

    Table 71. AstraZeneca Major Depressive Disorder Product

    Table 72. AstraZeneca Revenue in Major Depressive Disorder Business (2018-2023) & (US$ Million)

    Table 73. AstraZeneca Recent Development

    Table 74. Alkermes Company Detail

    Table 75. Alkermes Business Overview

    Table 76. Alkermes Major Depressive Disorder Product

    Table 77. Alkermes Revenue in Major Depressive Disorder Business (2018-2023) & (US$ Million)

    Table 78. Alkermes Recent Development

    Table 79. Takeda Pharmaceutical Company Detail

    Table 80. Takeda Pharmaceutical Business Overview

    Table 81. Takeda Pharmaceutical Major Depressive Disorder Product

    Table 82. Takeda Pharmaceutical Revenue in Major Depressive Disorder Business (2018-2023) & (US$ Million)

    Table 83. Takeda Pharmaceutical Recent Development

    Table 84. Naurex Company Detail

    Table 85. Naurex Business Overview

    Table 86. Naurex Major Depressive Disorder Product

    Table 87. Naurex Revenue in Major Depressive Disorder Business (2018-2023) & (US$ Million)

    Table 88. Naurex Recent Development

    Table 89. Euthymics Bioscience Company Detail

    Table 90. Euthymics Bioscience Business Overview

    Table 91. Euthymics Bioscience Major Depressive Disorder Product

    Table 92. Euthymics Bioscience Revenue in Major Depressive Disorder Business (2018-2023) & (US$ Million)

    Table 93. Euthymics Bioscience Recent Development

    Table 94. E-therapeutics Company Detail

    Table 95. E-therapeutics Business Overview

    Table 96. E-therapeutics Major Depressive Disorder Product

    Table 97. E-therapeutics Revenue in Major Depressive Disorder Business (2018-2023) & (US$ Million)

    Table 98. E-therapeutics Recent Development

    Table 99. Research Programs/Design for This Report

    Table 100. Key Data Information from Secondary Sources

    Table 101. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Major Depressive Disorder Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Major Depressive Disorder Market Share by Type: 2022 VS 2029

    Figure 3. Drugs Therapy Features

    Figure 4. Biological Therapy Features

    Figure 5. Meditation Features

    Figure 6. Physiothersapy Features

    Figure 7. Others Features

    Figure 8. Global Major Depressive Disorder Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 9. Global Major Depressive Disorder Market Share by Application: 2022 VS 2029

    Figure 10. Under 25 Years Old Case Studies

    Figure 11. 25-45 Years Old Case Studies

    Figure 12. Above 45 Years Old Case Studies

    Figure 13. Major Depressive Disorder Report Years Considered

    Figure 14. Global Major Depressive Disorder Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 15. Global Major Depressive Disorder Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 16. Global Major Depressive Disorder Market Share by Region: 2022 VS 2029

    Figure 17. Global Major Depressive Disorder Market Share by Players in 2022

    Figure 18. Global Top Major Depressive Disorder Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Major Depressive Disorder as of 2022)

    Figure 19. The Top 10 and 5 Players Market Share by Major Depressive Disorder Revenue in 2022

    Figure 20. North America Major Depressive Disorder Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 21. North America Major Depressive Disorder Market Share by Country (2018-2029)

    Figure 22. United States Major Depressive Disorder Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 23. Canada Major Depressive Disorder Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 24. Europe Major Depressive Disorder Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 25. Europe Major Depressive Disorder Market Share by Country (2018-2029)

    Figure 26. Germany Major Depressive Disorder Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. France Major Depressive Disorder Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. U.K. Major Depressive Disorder Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Italy Major Depressive Disorder Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Russia Major Depressive Disorder Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Nordic Countries Major Depressive Disorder Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Asia-Pacific Major Depressive Disorder Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. Asia-Pacific Major Depressive Disorder Market Share by Region (2018-2029)

    Figure 34. China Major Depressive Disorder Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. Japan Major Depressive Disorder Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. South Korea Major Depressive Disorder Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. Southeast Asia Major Depressive Disorder Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. India Major Depressive Disorder Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. Australia Major Depressive Disorder Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Latin America Major Depressive Disorder Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. Latin America Major Depressive Disorder Market Share by Country (2018-2029)

    Figure 42. Mexico Major Depressive Disorder Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Brazil Major Depressive Disorder Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Middle East & Africa Major Depressive Disorder Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. Middle East & Africa Major Depressive Disorder Market Share by Country (2018-2029)

    Figure 46. Turkey Major Depressive Disorder Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 47. Saudi Arabia Major Depressive Disorder Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 48. Pfizer Revenue Growth Rate in Major Depressive Disorder Business (2018-2023)

    Figure 49. Eli Lilly Revenue Growth Rate in Major Depressive Disorder Business (2018-2023)

    Figure 50. H. Lundbeck Revenue Growth Rate in Major Depressive Disorder Business (2018-2023)

    Figure 51. Otsuka Pharmaceutical Revenue Growth Rate in Major Depressive Disorder Business (2018-2023)

    Figure 52. AstraZeneca Revenue Growth Rate in Major Depressive Disorder Business (2018-2023)

    Figure 53. Alkermes Revenue Growth Rate in Major Depressive Disorder Business (2018-2023)

    Figure 54. Takeda Pharmaceutical Revenue Growth Rate in Major Depressive Disorder Business (2018-2023)

    Figure 55. Naurex Revenue Growth Rate in Major Depressive Disorder Business (2018-2023)

    Figure 56. Euthymics Bioscience Revenue Growth Rate in Major Depressive Disorder Business (2018-2023)

    Figure 57. E-therapeutics Revenue Growth Rate in Major Depressive Disorder Business (2018-2023)

    Figure 58. Bottom-up and Top-down Approaches for This Report

    Figure 59. Data Triangulation

    Figure 60. Key Executives Interviewed